The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor-infiltrating lymphocytes in ipsilateral breast tumor recurrences predict prognosis.
 
Axel Stenmark Tullberg
No Relationships to Disclose
 
Emma Nimeus-Malmström
No Relationships to Disclose
 
Fredrika Killander
No Relationships to Disclose
 
Martin Sjöström
Research Funding - PFS Genomics (Inst)
 
Henri A.J. Puttonen
No Relationships to Disclose
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; PFS Genomics; SerImmune
Honoraria - Genentech
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Celgene; EMD Serono; Genzyme; Janssen Biotech; Medivation/Astellas
Research Funding - Zenith Epigenetics
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Aniko Kovacs
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Roche
 
Dan Lundstedt
No Relationships to Disclose
 
Erik Holmberg
Patents, Royalties, Other Intellectual Property - Research contract with PFS genomics. IP regarding genomic profile.
 
Per Karlsson
Consulting or Advisory Role - Roche
Patents, Royalties, Other Intellectual Property - Contract with PFS genomics regarding of gen profile and intelectual property/royalties